Preventive Effect of Haobie Yangyin Ruajian Prescription on Hepatic Fibrosis Induced by CCl

SHUAI Hong-li; FANG Bu-wu; XING Wei; LIU Jie-ying

doi:10.11653/syfj2013160197

您当前的位置：

首页 >

文章列表页 >

Preventive Effect of Haobie Yangyin Ruajian Prescription on Hepatic Fibrosis Induced by CCl

更新时间：2024-01-04

- Preventive Effect of Haobie Yangyin Ruajian Prescription on Hepatic Fibrosis Induced by CCl
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 16, Pages: 197-201(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013160197
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
SHUAI Hong-li, FANG Bu-wu, XING Wei, et al. Preventive Effect of Haobie Yangyin Ruajian Prescription on Hepatic Fibrosis Induced by CCl[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(16): 197-201.
DOI：

SHUAI Hong-li, FANG Bu-wu, XING Wei, et al. Preventive Effect of Haobie Yangyin Ruajian Prescription on Hepatic Fibrosis Induced by CCl[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(16): 197-201. DOI： 10.11653/syfj2013160197.

摘要

目的: 探讨蒿鳖养阴软坚方对CCl4复合因素所致大鼠肝纤维化的预防作用及可能的作用机制。方法: 将大鼠随机分为正常对照组

模型组

蒿鳖养阴软坚方高、中、低剂量组(8.20

2.59

0.82 g·kg-1)

复方鳖甲软肝片组(0.54 g·kg-1)

秋水仙碱组(1×10-4 g·kg-1)。第1次sc CCl4 5 mL·kg-1

从第2次开始每隔3 d sc 40%CCl4花生油3 mL·kg-1至第12次; 模型组和治疗组隔日ig 30%乙醇(1 mL/只)

各治疗组每日给药1次

正常组和模型组均给予相应体积的蒸馏水

每周6 d(停药1 d)

共6周。观测肝组织形态和胶原蛋白

测定血清肝功能丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST);放免法测定血清透明质酸(HA)、IV型胶原(IV-C)、III型前胶原(PCIII)

层黏连蛋白(LN)水平;紫外-可见分光光度法测定血清丙二醛(MDA)水平;检测肝组织中羟脯氨酸

胶原蛋白及白蛋白含量。结果: 模型组大鼠肝组织内肝细胞广泛变性及坏死

大量炎性细胞浸润

类假小叶形成

大量胶原纤维形成;蒿鳖养阴软坚方高剂量组的肝脏病理变化程度较模型组明显减轻且无类假小叶形成;模型组的ALT

AST

HA及PCIII含量均高于正常对照组( P<0.01

P<0.05);各蒿鳖养阴软坚方给药组ALT

AST

HA及PCIII高剂量组显著低于模型组(P<0.05); MDA及胶原蛋白的含量均低于模型组(P<0.01)

各蒿鳖养阴软坚方给药组白蛋白均高于模型组(P<0.01)。结论: 蒿鳖养阴软坚方对四氯化碳复合因素诱导的大鼠肝纤维化有预防作用;其作用机制可能与抗脂质过氧化损伤

抗炎

抑制胶原蛋白的合成等有关。

Abstract

Objective: To study the preventive effects of Haobie Yangyin Ruajian prescription (HBYYRJ) on rat hepatic fibrosis induced in rats by CCl4 and explore the effective mechanisms. Method: Rats were randomly divided into 7 groups:normal control group

model group

high

middle and low dose of HBYYRJ groups(8.20

2.59

0.82 g·kg-1)

compound Biejia Ruangan table group(0.54 g·kg-1)

colchicin group(1×10-4 g·kg-1). First CCl4 5 mL·kg-1 was given by sc

40% CCl4-peanut oil 3 mL·kg-1 was given by sc every three days from the second time to the twelfth time; 30% alcohol (1 mL) was ig given to model group and therapeutic groups every other day

drugs were given to the rats in therapeutic groups for six consecutive weeks

distilled water was given to the rats of normal and model groups. Histological observation of the liver tissue and collagen content were carried out. Blood serum was used for measuring the contents of alanine transaminase(ALT)

aspartate aminotransferase(AST)

hyaluronic acid(HA)

laminin(LN)

type III procollagen(PCIII)

type IV collagen(IVC)

albumin(ALB). The content of malondialdehyde (MDA) was detected by ultraviolet visible spectrophotometry. The content of hydroxyproline

collagen and albumin were detected in liver tissue. Result: The degeneration and necrosis

inflammatory cell infiltration

false lobular formation

and a large number of collagen fiber depositions were observed in liver tissue of the model group.The level of chronic hepatic damage was improved greatly and none of the false lobular was formed in the high dose of HBYYRJ. The contents of ALT

AST

HA and PCIII of the model group were significantly higher than that in normal group (P<0.01

P<0.05). The content of ALT

AST

HA and PCIII of HBYYRJ groups was significantly lower than that in model group (P<0.05). The content of MDA and collagen in liver tissue of HBYYRJ groups was lower than that in model group (P<0.01). The content of ALB of the high dose of HBYYRJ was significantly higher than that in model group (P<0.01). Conclusion: HBYYRJ has preventive effects on hepatic fibrosis in rats induced by CCl4.The mechanism might be associated with anti-lipid peroxidation

antiinflammation and restraining the compose of collagen protein.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Effect of Dendrobium officinale Polysaccharides in Reversing Hepatic Fibrosis in Rats via Notch Signaling Pathway and Ultrasound Evaluation

Efficacy of Tiaogan Huaxian Pills in Prevention and Treatment of Hepatic Fibrosis in Hepatitis B and Its Effect on Diffusion-weighted Imaging

Traditional Chinese Medicine Treats Hepatic Fibrosis via NF-κB Signaling Pathway： A Review

Traditional Chinese Medicine Against Liver Fibrosis Based on Autophagy： A Review

Analysis of Mechanism of Qinggan Jianpi Huoxue Prescription in Treatment of Hepatic Fibrosis Rats by Regulating M1/M2 Macrophages

Related Author

XU Ying

LUO Jina

YANG Liuqing

TIAN Qianqian

CHENG Jiamao

CHEN Haiyan

DAI Haiyang

HUANG Guye

Related Institution

The First Affiliated Hospital of Dali University，Dali

School of Basic Medical Sciences，Dali University，Dali

Dali Bai Autonomous Prefecture People's Hospital，Dali

School of Clinical Medicine，Dali University，Dali

The First Affiliated Hospital of Guangxi University of Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰